Joseph M. Benesch
CFO & Corporate ControllerMr. Joseph M. Benesch serves as Interim Chief Financial Officer at Journey Medical Corporation since January 27, 2023 until April 26, 2024 and serves as its Chief Financial Officer from April 26, 2024 and hired as the Company’s Corporate Controller in November 2021. He is Principal Accounting Officer of Teligent, Inc. from September 23, 2021. He has served Corporate Controller at Journey Medical Corporation since November 2021. From June 2021 to November 2022, he served as the Principal Accounting Officer, Vice President and Corporate Controller of Teligent Pharma Inc. He held senior financial management positions of increasing responsibility from Corporate Controller to Vice President of Finance at Savient Pharmaceuticals. He is with Teligent, Inc. since in June 2021 as its Vice President and Corporate Controller and has experience in financial reporting, financial operations, business transactions strategy and all phases of the accounting and controls process. Prior to joining the Company, Mr. Benesch was the Controller at Torrent, Inc. from November 2018 to June 2021, served as a financial reporting consultant for the Pine Hill Group from November 2017 to November 2018, was the Corporate Controller at Adare Pharmaceuticals, Inc. from April 2017 to November 2017 and served as Vice President Finance at Edenbridge Pharmaceuticals, LLC from November 2015 to April 2017. From December 2005 to April 2007, Mr. Benesch served as Vice President Finance for Merrill Lynch. From November 2018 to June 2021, Mr. Benesch served as Corporate Controller of Torrent Pharmaceuticals Ltd. He began his career in the public accounting sector at Baker Tilly Virchow Krause, LLP and Ernst and Young Global Limited, working with a diverse client base. From November 1998 to December 2005, he served as Director of Financial Reporting for Prudential Financial. Mr. Benesch received his B.A. in Accounting from Wilkes University and is a Certified Public Accountant.
Positions
- Company NameJourney Medical CorporationStock CodeDERMPositionCFO & Corporate ControllerColleagues
- LALindsay Allan RosenwaldExecutive Chairman
- CMClaude MaraouiFounder, President, CEO & Director
- RARamsey AlloushCOO, General Counsel & Company Secretary
- BPBrian ProutExecutive Director of Marketing
- NHNeil HerskowitzIndependent Director
- JSJustin SmithIndependent Director
- MJMiranda J. ToledanoIndependent Director
